We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dynamic Data Collection System Devised for Healthcare Concept Tests

By LabMedica International staff writers
Posted on 01 Apr 2009
A new dynamic data collection solution has been developed that allows researchers to quickly test concepts with physicians across a range of specialty segments globally.

All Global, a global healthcare data collection agency located in New York (NY, USA) and London (UK), has introduced the AllTest, which utilizes All Global's online panel of physicians and advanced programming capabilities to produce data in a matter of days.

"This online approach provides a media-rich forum for quickly assessing the viability of certain concepts for all researchers. More...
All Global believes that, by incorporating an engaging respondent experience with the quality of our panel and services, data can be incorporated into decisions in a meaningful, timely way," commented the company's CEO, Tony Burke. "All Global does a tremendous job of addressing the needs of the healthcare market research industry. AllTest is another example of that."

AllTest combines advanced programming techniques in its concept presentation and survey administration. It is designed to present a more maximized survey experience for the respondent while also remaining flexible enough to incorporate opinions from physicians across numerous specialties including, but not limited to, general practice, internal medicine, oncology, cardiology, and endocrinology. The depth of specialties, global reach, and significant sample sizes converge in AllTest's aggressive timeline of less than six days from receiving materials.

"AllTest combines rapid turnaround with worldwide physician panel access while raising the bar on quality practices for a reasonable budget," said Terence McCarron, All Global's executive vice president, global business development.

All Global is a provider of data collection services to the medical and healthcare market research industry worldwide. All Global enables healthcare/pharmaceutical marketing researchers to offer a wider range of data collection solutions to their clients.

Related Links:

All Global



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.